PDCD1 and neoplasm: Hsu et al. [74] demonstrated in murine models of allogeneic skin transplantation and syngeneic subcutaneous and orthotopic HCC models that the combination of high-dose Tacrolimus and PD-1 blockade was able to reduce tumor growth while preventing AR.